When Vsee Health, Inc. reports, what it reported each quarter, and how the stock took the results.
21 quarters. Jun 30, 2021 to Sep 30, 2026. USD.
10-K due Mar 26 – Apr 16
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 4 filings.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
| Q3 2026 | Sep 30, 2026 | — | Nov 17, 2026 | 48 d | 10-Q | $1.50M | −35.5% | -$3.88 | — |
|---|
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $1.56M | +48.0% | -$0.06 | — |
|---|
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | $3.16M | −4.9% | -$0.05 | 2.3% |
|---|
| FY 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Mar 31, 2026 | 90 d | 10-K | $7.92M | +112.2% | — | 4.0% | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | $2.32M | −30.9% | -$0.02 | 5.4% | |
| Q2 2025 | Jun 30, 2025 | — | Oct 15, 2025 | 107 d | 10-Q | $1.06M | −38.3% | -$0.16 | 13.3% | |
| Q1 2025 | Mar 31, 2025 | — | Oct 15, 2025 | 198 d | 10-Q | $3.32M | +104.9% | -$0.24 | 13.3% | |
| FY 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Aug 28, 2025 | 240 d | 10-K | $3.73M | +151.6% | — | 21.8% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | $3.35M | +134.1% | -$3.58 | +0.8% | |
| Q2 2024 | Jun 30, 2024 | Sep 23, 2024 · after-hours | Sep 23, 2024 | 85 d | 10-Q | $1.71M | +34.6% | -$0.12 | 1.8% | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $1.62M | +2.8% | $0.01 | — | |
| FY 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Apr 12, 2024 | 103 d | 10-K | $1.48M | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 20, 2023 | 51 d | 10-Q | $1.43M | — | -$0.02 | — | |
| Q2 2023 | Jun 30, 2023 | — | Aug 21, 2023 | 52 d | 10-Q | $1.27M | — | -$0.11 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | $1.58M | — | -$0.05 | — | |
| FY 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Apr 12, 2023 | 102 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 10, 2022 | 41 d | 10-Q | — | — | -$0.05 | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | -$0.04 | — | |
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | — | — | -$0.04 | — | |
| FY 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2021 | Sep 30, 2021 | — | — | — | — | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | — | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
The stock’s move from the last close before each release to the first close after it, over the last 8 releases. Largest: −21.8% after Q4 2024.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.